GHENT, BELGIUM– – Ablynx [Euronext Brussels: ABLX] todayannouncedthat Boehringer Ingelheim has submitted a Clinical Trials Application tothe European regulatory authorities to start a Phase I clinical …
Continued here:
Nanobody for ... continue reading
( Northwestern University ) Alzheimer's disease drugs now being tested in clinical trials may have potentially adverse side effects. A study with mice suggests the drugs could act like a bad electrician, causing neurons to be miswired and interfering with their ability to send messages to the brain. Ironically, they ... continue reading
VANCOUVER, British Columbia, Feb. 18 (UPI) — Alzheimer's drugs currently being tested in clinical trials might hurt wiring in the brain and nervous system, U.S. researchers said.
Follow this link:
Alzheimer's drug may damage brain wiring
People who have no symptoms of Alzheimer’s disease but who have an abnormal protein believed to be a hallmark of the illness should be enrolled in clinical trials to test whether drugs can head off the disease, according to a team of researchers led by a scientist at Boston’s Brigham ... continue reading
Since the approval of four cholinesterase inhibitors in the 1990s and memantine in 2003, there have been no new treatments for Alzheimer’s disease. Against this backdrop, Paul Aisen of the University of California, San Diego, opened the 4th International Conference on Clinical Trials on Alzheimer’s Disease (CTAD) on 3 November ... continue reading